Clinical trial
Redox Imbalance and the Development of Cystic Fibrosis Diabetes
NCT02202876 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Redox Imbalance and the Development of Cystic Fibrosis Diabetes
- Lead sponsor
- Emory University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- September 9, 2018
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.